Lilly breaks ground on $5 billion Richmond facility to produce API and finished medicines
Eli Lilly and Company announced on Oct. 22, 2026 that it broke ground on a $5 billion manufacturing facility just west of Richmond, Virginia, the company's first fully integrated site to produce both active pharmaceutical ingredients and finished antibody-drug conjugates. The new plant is expected to create 650 high-wage jobs and about 1,800 construction jobs during construction.
Primary source
Company press release (PR Newswire), October 22, 2026
Lilly breaks ground in Richmond to expand American manufacturing of next-generation cancer medicines, advancing its build-out of 10 new U.S. sites since 2020
Machine-summarized from the source above; not independently reported. How we use automation